Federal Register of Legislation - Australian Government

Primary content

PB 74 of 2021 Other as made
This instrument amends the National Health (Listing of Pharmaceutical Benefits) Instrument 2012 to make changes to the pharmaceutical benefits listed on the Pharmaceutical Benefits Scheme and related matters.
Administered by: Health
Registered 31 Jul 2021
Tabling HistoryDate
Tabled HR03-Aug-2021
Tabled Senate03-Aug-2021
Date of repeal 19 Oct 2021
Repealed by Division 1 of Part 3 of Chapter 3 of the Legislation Act 2003

Pharmaceutical Benefits Advisory Committee

 

 

 

Email:                    PBAC@health.gov.au                                                                       Address all mail to:

                                                                                                                                                PBAC Secretariat

                                                                                                                                                GPO Box 9848

                                                                                                                                                Canberra  ACT 2601

 


DELETION OF PHARMACEUTICAL BENEFIT ITEM(S)

EFFECTIVE 1 August 2021

 

Following is the advice of the Pharmaceutical Benefits Advisory Committee concerning the deletion of items from the declaration under subsections 85(2) and 85(2A) of the National Health Act 1953, with effect from the above date.

 

Item

PBAC Advice

 

Red Syrup APF 15

The PBAC reviewed the ongoing clinical need for Red Syrup APF 15 following correspondence from the Australian Pharmaceutical Formulary editorial board.

 

The PBAC considered that the deletion would not result in an unmet clinical need.

 

 

 

 

 

Paraffin, Soft Yellow BP

The PBAC considered that the deletion of Paraffin, Soft Yellow BP would not result in an unmet clinical need.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Vanessa McMahon

Director

PBAC Assessment Section

Office of Health Technology Assessment

Technology Assessment and Access Division

19 July 2021